Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer

Figure 1 Study flow chart. ¹Defined as the American Society of Anesthesiologists classification > III or New York Heart Association classification> II. ²Defined as Clavien-Dindo classification > II. DM: Diabetes mellitus; TNM: Tumor-node-metastasis.

Figure 2 Comparisons of the prognostic outcomes of patients in the non-diabetes mellitus, diabetes mellitus, well-controlled and poorly controlled groups. A: Comparison of disease-free survival rates between the non-diabetes mellitus (DM) and DM groups (P = 0.178); B: Comparison of overall survival rates between the non-DM and DM groups (P = 0.638); C: Comparison of disease-free survival rates between the well-controlled and poorly controlled groups (P = 0.021); D: Comparison of overall survival rates between the well-controlled and poorly controlled groups (P = 0.011). DFS: Disease-free survival; OS: Overall survival.